The landscape of dementia analysis has progressed radically with the appearance of complex biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent exams that will detect Alzheimer's pathology many years before indications arise. Although these technological advances stand for extraordinary progress in being familiar with neurodegenerative conditions, they have https://mildcognitiveimpairmenttr00098.bloggip.com/38249748/the-enduring-price-of-cognitive-evaluation-for-older-older-people